Table 3.
Blood Pressure During First Follow‐Up Correlates With baPWV During Baseline
| Population | Dependent Variables During First Follow‐up | Estimated Regression Coefficient | Standard Error | F Value | P Value |
|---|---|---|---|---|---|
| Total | SBP | 0.75 | 0.09 | 63.7 | <.0001 |
| Male | SBP | 0.52 | 0.12 | 19.15 | <.0001 |
| Female | SBP | 1.08 | 0.17 | 42.85 | <.0001 |
| Total | DBP | 0.33 | 0.05 | 36.94 | <.0001 |
| Male | DBP | 0.24 | 0.07 | 12.55 | <.0001 |
| Female | DBP | 0.47 | 0.07 | 41.88 | <.0001 |
| Total | PP | 0.53 | 0.07 | 60.85 | <.0001 |
| Male | PP | 0.41 | 0.09 | 22.23 | <.0001 |
| Female | PP | 0.75 | 0.13 | 35.7 | <.0001 |
| Total | MAP | 0.48 | 0.05 | 91.43 | <.0001 |
| Male | MAP | 0.34 | 0.06 | 27.64 | <.0001 |
| Female | MAP | 0.78 | 0.09 | 78.22 | <.0001 |
Abbreviations: baPWV, brachial‐ankle pulse wave velocity; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; SBP, systolic blood pressure. The initial variables for stepwise regression include baPWV, corresponding baseline blood pressure (eg, baseline SBP and first follow‐up SBP), age, sex, height, body mass index, postmenopausal, current smoker, current alcohol drinkers, exercise, high salt intake, hypoglycemic agents, antihypertensive agents, lipid‐lowering agents, heart rate, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, total cholesterol, triglyceride, serum creatinine, fasting glucose, C‐reactive protein, homocysteic acid, uric acid, and time to first follow‐up.